GO:0006357 regulation of transcription by RNA polymerase II: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006357 describes any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
• RNA polymerase II transcription is controlled at initiation, pause release, elongation, and termination by multisubunit complexes such as Integrator, P-TEFb, and SPT5.
• Biomolecular condensates concentrate transcription factors and RNA polymerase II to regulate gene expression.
• Dysregulation of RNA polymerase II transcription is linked to cancer, neurodevelopmental disorders, and other diseases.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of transcriptional regulators.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study GO:0006357-related genes.
Description
Regulation of transcription by RNA polymerase II (GO:0006357) encompasses all processes that modulate the frequency, rate, or extent of RNA polymerase II (Pol II)-mediated transcription. This includes the recruitment of Pol II to promoters, the transition from initiation to elongation, and the coordination of transcription with RNA processing. Because Pol II transcribes protein-coding genes and many noncoding RNAs, its regulation is central to cell identity, development, and stress responses. Researchers study GO:0006357 to understand how gene expression programs are established and how their disruption leads to disease. The term covers both global and gene-specific regulatory events, from enhancer-promoter communication to termination.
regulation of transcription by RNA polymerase II At A Glance
| GO ID | GO:0006357 |
|---|---|
| GO term | regulation of transcription by RNA polymerase II |
| Ontology | biological_process |
| Synonym | regulation of transcription from RNA polymerase II promoter; global transcription regulation from Pol II promoter; regulation of gene-specific transcription from RNA polymerase II promoter |
| Major function | Modulates the frequency, rate or extent of transcription mediated by RNA polymerase II |
| Related processes | Transcription initiation, promoter escape, pause release, elongation, termination, and RNA processing |
| Key regulators | Integrator complex, P-TEFb, SPT5, biomolecular condensates, H3K4 methylation machinery |
| Disease relevance | Cancer, neurodevelopmental disorders, and other diseases linked to transcriptional dysregulation |
What Is GO:0006357?
GO:0006357 is defined as any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. In other words, it includes all molecular events that control when, where, and how much Pol II transcribes a given gene. This regulation can be global, affecting many genes, or gene-specific, and it operates at multiple steps including initiation, elongation, and termination.
Why Is regulation of transcription by RNA polymerase II Important in Cell Biology?
Regulation of transcription by RNA polymerase II is fundamental to all cellular decisions because it determines which genes are expressed and at what levels. It integrates signals from enhancers, chromatin modifications, and transcription factors to shape transcriptomes. Defects in this regulation cause a broad range of human diseases, including cancer and developmental disorders. Understanding GO:0006357 is therefore essential for basic biology and for therapeutic development.
• Controls expression of protein-coding genes and many noncoding RNAs.
• Coordinates transcription with RNA processing through the Integrator complex.
• Regulates promoter-proximal pausing and elongation via P-TEFb and SPT5.
• Involves biomolecular condensates that concentrate transcription machinery.
• Linked to cancer through dysregulation of H3K4 methylation and transcription factors.
• Affects neurodevelopment and other diseases when core regulators are mutated.
• Provides targets for therapeutic intervention in transcriptional addictions.
• Enables CRISPR screens to identify causal transcriptional regulators.
• Requires precise experimental models to dissect gene-specific versus global effects.
• Underpins responses to environmental and developmental signals.
What Happens During regulation of transcription by RNA polymerase II?
Initiation and promoter recognition
In simple terms: This is the step where the cell decides to start reading a gene.
Regulation of transcription by RNA polymerase II begins with the assembly of general transcription factors and Pol II at core promoters. This step is influenced by enhancers, chromatin state, and sequence-specific transcription factors. Biomolecular condensates can concentrate these components to facilitate initiation.
Promoter-proximal pausing and pause release
In simple terms: Pol II often pauses shortly after starting, and release from this pause is a key control point.
After initiation, Pol II frequently pauses near the promoter. The positive transcription elongation factor b (P-TEFb) phosphorylates the Pol II C-terminal domain and negative elongation factors to release paused Pol II into productive elongation. SPT5 stabilizes Pol II and orchestrates transcription cycles, including pause release.
Elongation and co-transcriptional RNA processing
In simple terms: While Pol II reads the gene, the RNA is processed at the same time.
During elongation, the Integrator complex associates with Pol II and regulates both transcription and RNA processing, including 3' end formation of snRNAs and other noncoding RNAs. The INTAC endonuclease and phosphatase modules differentially regulate transcription by Pol II.
Termination and recycling
In simple terms: The process ends when Pol II stops and is recycled for new rounds.
Termination of transcription by Pol II involves cleavage and polyadenylation signals and is coupled to RNA 3' end processing. Proper termination is required to prevent read-through and to maintain transcription cycles.
Key Genes Involved in GO:0006357 regulation of transcription by RNA polymerase II
The following genes and protein complexes are central to the regulation of transcription by RNA polymerase II (GO:0006357).
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR2A | Catalytic subunit of RNA polymerase II | Core enzyme for all Pol II transcription; target for inhibition studies |
| SPT5 (SUPT5H) | Stabilizes Pol II and regulates pause release | Key elongation regulator; knockout affects enhancer landscape |
| CDK9 | Kinase subunit of P-TEFb | Phosphorylates Pol II CTD and negative elongation factors; master regulator of elongation |
| CCNT1 | Cyclin T1, regulatory partner of CDK9 | Forms P-TEFb; required for pause release |
| INTS11 | Integrator complex subunit with endonuclease activity | Regulates snRNA 3' processing and transcription |
| INTS10 | Integrator complex subunit | Gene-specific regulation of transcription |
| INTAC (INTS complex) | Endonuclease and phosphatase modules | Differentially regulates transcription by Pol II |
| KMT2A (MLL1) | H3K4 methyltransferase | Deposits H3K4me3 at promoters; links chromatin to transcription |
| KMT2D | H3K4 methyltransferase | Enhancer regulation; mutations in Kabuki syndrome |
| WDR5 | Core subunit of H3K4 methyltransferase complexes | Scaffold for KMT2 complexes; target for small molecules |
| RBBP5 | Core subunit of H3K4 methyltransferase complexes | Required for H3K4 methylation and transcription |
| ASH2L | Core subunit of H3K4 methyltransferase complexes | Stimulates methyltransferase activity |
| BRD4 | Bromodomain protein that recruits P-TEFb | Reader of acetylated histones; links chromatin to elongation |
| MED1 | Mediator complex subunit | Connects enhancers to Pol II |
| CTD (POLR2A C-terminal domain) | Phosphorylation platform | Integrates initiation, elongation, and processing signals |
| NELFA | Negative elongation factor | Maintains promoter-proximal pausing |
| NELFB | Negative elongation factor | Inhibits elongation until P-TEFb acts |
How Is regulation of transcription by RNA polymerase II Regulated?
Regulation of transcription by RNA polymerase II is itself controlled by signaling pathways and chromatin modifiers. For example, P-TEFb activity is regulated by its association with 7SK snRNP and by upstream kinases. H3K4 methylation, deposited by KMT2 complexes, provides a chromatin mark that influences transcription. Biomolecular condensates can dynamically concentrate or exclude transcription factors to modulate Pol II activity. The Integrator complex is regulated by its subunit composition and post-translational modifications to achieve gene-specific effects.
regulation of transcription by RNA polymerase II and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KMT2A | Leukemia, transcriptional dysregulation | Knockout and point mutation in hematopoietic cell lines |
| KMT2D | Kabuki syndrome, neurodevelopmental disorder | Knock-in of patient mutations in iPSCs |
| CDK9 | Cancer, transcriptional addiction | Overexpression and knockout in cancer cell lines |
| INTS11 | Neurodevelopmental disorders, snRNA processing defects | Knockout in neuronal progenitors |
| BRD4 | Cancer, inflammation | Knockout and degron knock-in in cancer models |
Cancer
Dysregulation of RNA polymerase II transcription is a hallmark of cancer. Mutations in H3K4 methyltransferases such as KMT2A and KMT2D alter gene expression programs and are found in leukemias and solid tumors. Overexpression of P-TEFb components or BRD4 can drive oncogenic transcription. Targeting transcriptional kinases like CDK9 is an active therapeutic strategy.
Neurodevelopmental disorders
Mutations in genes encoding Integrator subunits or chromatin regulators cause neurodevelopmental disorders. For example, mutations in KMT2D cause Kabuki syndrome, characterized by intellectual disability and developmental delay. Proper regulation of Pol II transcription is essential for neuronal differentiation and function.
Other diseases
Defects in transcription termination and RNA processing are linked to diseases such as spinal muscular atrophy and certain autoimmune conditions. The Integrator complex is also implicated in viral infections and immune responses.
From regulation of transcription by RNA polymerase II-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SPT5 affect Pol II stability and enhancer landscape? | Knockout of SUPT5H in HEK293T or MEFs |
| How do Integrator mutations alter snRNA processing? | Point mutation of INTS11 endonuclease domain |
| What is the effect of P-TEFb inhibition on pause release? | Knock-in of CDK9 gatekeeper mutation or overexpression |
| How do H3K4 methylation marks regulate transcription? | Knockout of KMT2A/KMT2D and rescue with catalytic mutants |
| Can condensates modulate Pol II activity? | Overexpression of condensate-forming transcription factors |
| What genes are essential for Pol II termination? | CRISPR knockout library screening for termination factors |
How to Study the regulation of transcription by RNA polymerase II Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state RNA levels | Global effects of transcription regulator knockout |
| PRO-seq | Engaged RNA polymerase II | Pause release and elongation dynamics |
| ChIP-seq | Protein-DNA binding and histone marks | H3K4 methylation and Pol II occupancy |
| Mass spectrometry | Protein interactions and modifications | Integrator and P-TEFb complex composition |
| FRAP | Condensate dynamics | Biomolecular condensate regulation |
| CRISPR screen | Gene essentiality and modifiers | Identification of transcription regulators |
| Nascent RNA labeling | Transcription rate | Real-time Pol II activity |
| 3C/Hi-C | Chromatin architecture | Enhancer-promoter interactions |
Transcriptomics (RNA-seq, PRO-seq, ChIP-seq)
RNA-seq measures steady-state RNA levels, while PRO-seq and ChIP-seq detect engaged Pol II and chromatin marks. These methods reveal how regulators affect initiation, pausing, and elongation.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry identifies protein-protein interactions within transcription complexes such as Integrator and P-TEFb. Phosphoproteomics can map Pol II CTD phosphorylation states.
Imaging and condensate analysis
Live-cell imaging and fluorescence recovery after photobleaching (FRAP) assess biomolecular condensate dynamics and their role in transcription regulation.
CRISPR screens
Genome-wide CRISPR knockout or interference screens identify genes that regulate Pol II transcription under specific conditions.
How CRISPR Can Be Used to Study GO:0006357 regulation of transcription by RNA polymerase II
Knockout
CRISPR knockout of genes such as SUPT5H, CDK9, or INTS11 can reveal their essential roles in Pol II transcription. For example, SPT5 knockout destabilizes Pol II and alters enhancer landscapes. Integrator subunit knockouts affect snRNA processing and gene expression.
Point Mutation
Point mutations can dissect catalytic activities, such as the endonuclease domain of INTS11 or the kinase domain of CDK9. These models separate enzymatic functions from scaffolding roles.
Knock-in
Knock-in of epitope tags or patient mutations allows tracking of endogenous proteins and modeling disease variants. For example, tagging POLR2A with GFP enables live-cell imaging of transcription.
Overexpression
Overexpression of transcription factors or condensate-forming proteins can drive transcriptional programs and test sufficiency. Overexpression of BRD4 or P-TEFb components enhances elongation.
How EDITGENE Supports regulation of transcription by RNA polymerase II Research
Researchers studying regulation of transcription by RNA polymerase II-related genes often need to determine whether a candidate gene is causally involved in a specific transcriptional program or disease phenotype. EDITGENE provides validated CRISPR cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for regulation of transcription by RNA polymerase II research.
Frequently Asked Questions About regulation of transcription by RNA polymerase II
What is GO:0006357?
GO:0006357 is the Gene Ontology term for regulation of transcription by RNA polymerase II, defined as any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
What genes are involved in regulation of transcription by RNA polymerase II?
Key genes include POLR2A, SUPT5H, CDK9, CCNT1, INTS11, KMT2A, KMT2D, and BRD4, among others.
How is RNA polymerase II transcription regulated?
It is regulated at initiation, pause release, elongation, and termination by complexes such as P-TEFb, Integrator, and SPT5, as well as by chromatin modifications and condensates.
What diseases are linked to defects in RNA polymerase II transcription?
Dysregulation is linked to cancer, neurodevelopmental disorders like Kabuki syndrome, and other conditions.
What is the role of P-TEFb in transcription?
P-TEFb phosphorylates the Pol II C-terminal domain and negative elongation factors to release paused Pol II into productive elongation.
How does the Integrator complex regulate transcription?
Integrator associates with Pol II and regulates transcription and RNA processing, including snRNA 3' end formation, with gene-specific effects.
What are biomolecular condensates in transcription?
They are membraneless compartments that concentrate transcription factors and Pol II to modulate gene expression.
How can CRISPR be used to study transcription regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of transcriptional regulators.
What methods are used to study RNA polymerase II transcription?
Common methods include RNA-seq, PRO-seq, ChIP-seq, mass spectrometry, FRAP, and CRISPR screens.
Why is H3K4 methylation important for transcription?
H3K4 methylation is a chromatin mark deposited by KMT2 complexes that influences transcription and is linked to disease.
Conclusion
Regulation of transcription by RNA polymerase II (GO:0006357) is a central biological process that controls gene expression programs through coordinated actions of initiation, elongation, and termination factors. Its dysregulation underlies many human diseases, making it a key area for research and therapeutic targeting. CRISPR-based models and functional genomics provide powerful tools to dissect these mechanisms.
References
- 1. Pei G et al.. 2025. Transcription regulation by biomolecular condensates.. Nat Rev Mol Cell Biol 26(3):213-236 PMID: 39516712
- 2. Hu S et al.. 2023. INTAC endonuclease and phosphatase modules differentially regulate transcription by RNA polymerase II.. Mol Cell 83(10):1588-1604.e5 PMID: 37080207
- 3. Hu S et al.. 2021. SPT5 stabilizes RNA polymerase II, orchestrates transcription cycles, and maintains the enhancer landscape.. Mol Cell 81(21):4425-4439.e6 PMID: 34534457
- 4. Wang H et al.. 2025. Roles of H3K4 methylation in biology and disease.. Trends Cell Biol 35(2):115-128 PMID: 38909006
- 5. Welsh SA et al.. 2023. Genomic regulation of transcription and RNA processing by the multitasking Integrator complex.. Nat Rev Mol Cell Biol 24(3):204-220 PMID: 36180603
- 6. Fujinaga K et al.. 2023. P-TEFb: The master regulator of transcription elongation.. Mol Cell 83(3):393-403 PMID: 36599353
- 7. Arndt KM et al.. 2015. Termination of Transcription of Short Noncoding RNAs by RNA Polymerase II.. Annu Rev Biochem 84:381-404 PMID: 25747400
- 8. Sabath K et al.. 2024. Basis of gene-specific transcription regulation by the Integrator complex.. Mol Cell 84(13):2525-2541.e12 PMID: 38906142
